The DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index; 9 of the 172 sources its claims cite were checked for support.
Nicotine is a Selective Pharmacological Chaperone of Acetylcholine Receptor Number and Stoichiometry. Implications for Drug Discovery
Open accessAbstract
The acronym SePhaChARNS, for "selective pharmacological chaperoning of acetylcholine receptor number and stoichiometry," is introduced. We hypothesize that SePhaChARNS underlies classical observations that chronic exposure to nicotine causes "upregulation" of nicotinic receptors (nAChRs). If the hypothesis is proven, (1) SePhaChARNS is the molecular mechanism of the first step in neuroadaptation to chronic nicotine; and (2) nicotine addiction is partially a disease of excessive chaperoning. The chaperone is a pharmacological one, nicotine; and the chaperoned molecules are alpha4beta2* nAChRs. SePhaChARNS may also underlie two inadvertent therapeutic effects of tobacco use: (1) the inverse correlation between tobacco use and Parkinson's disease; and (2) the suppression of seizures by nicotine in autosomal dominant nocturnal frontal lobe epilepsy. SePhaChARNS arises from the thermodynamics of pharmacological chaperoning: ligand binding, especially at subunit interfaces, stabilizes AChRs during assembly and maturation, and this stabilization is most pronounced for the highest-affinity subunit compositions, stoichiometries, and functional states of receptors. Several chemical and pharmacokinetic characteristics render exogenous nicotine a more potent pharmacological chaperone than endogenous acetylcholine. SePhaChARNS is modified by desensitized states of nAChRs, by acid trapping of nicotine in organelles, and by other aspects of proteostasis. SePhaChARNS is selective at the cellular, and possibly subcellular, levels because of variations in the detailed nAChR subunit composition, as well as in expression of auxiliary proteins such as lynx. One important implication of the SePhaChARNS hypothesis is that therapeutically relevant nicotinic receptor drugs could be discovered by studying events in intracellular compartments rather than exclusively at the surface membrane.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
The paper introduces SePhaChARNS—selective pharmacological chaperoning of acetylcholine receptor number and stoichiometry—as a hypothesis for how chronic nicotine upregulates α4β2* nicotinic receptors. It argues this mechanism may explain nicotine addiction, the inverse smoking–Parkinson’s disease association, and ADNFLE seizure suppression, and implies drug discovery should target intracellular ER events.
Key findings
- SePhaChARNS proposes that chronic nicotine acts as a pharmacological chaperone in the endoplasmic reticulum, stabilizing high-affinity α4β2* nAChR stoichiometries; upregulation is described as post-translational, cell-autonomous, and receptor-autonomous. The high- and low-sensitivity α4β2 forms differ by 50- to 100-fold in nicotine EC50 (~1 and ~100 μM), and nicotine shows an EC50 of <100 nM for upregulation in clonal cell lines transfected with α4 and β2 subunits.
- Nicotine differs from ACh in duration and access: nicotine disappears from blood with a half-life of ~120 min, whereas ACh remains near receptors for <1 ms; nicotine permeates membranes and acid-traps in organelles, with pH 6.5 giving a threefold higher organelle concentration and pH 5.5 giving a 30-fold ratio. Nicotine’s EC50 is ~1 μM at (α4)2(β2)3 neuronal receptors versus ~400 μM at (α1)2β1γδ muscle receptors.
- Chronic nicotine cell-selectively upregulates functional α4* nAChRs in VTA GABAergic neurons and the medial perforant path, effects linked to tolerance, locomotor sensitization, and cognitive sensitization. The paper also links SePhaChARNS to Parkinson’s disease protection and ADNFLE, and notes CHRNA5/A3/B4 variants rs16969968 and rs578776 (r² = 0.18) in nicotine dependence, plus lynx1 making α4β2 nAChRs up to 20-fold less sensitive to ACh.
- A major drug-discovery implication is that medically relevant manipulations of α4β2* nAChRs may occur in the ER rather than at the surface membrane, so drugs affecting SePhaChARNS might be discovered by studying intracellular compartments and proteostasis.
Methods
- Design: review/hypothesis paper introducing the acronym SePhaChARNS; it is not a primary experimental study.
- Data or sample: synthesis of published literature and unpublished data from the authors’ laboratories, including cited unpublished results from C. Xiao and H. Lester, submitted work by C. Son et al., and unpublished haplotype data from A. M. Goate, J. Wang, and L. Bierut.
- Main analysis: conceptual and thermodynamic argument linking ligand binding, receptor assembly/maturation, stoichiometry, desensitization, acid trapping, proteostasis, and accessory-subunit/genetic data.
Limitations
- Stated in the paper: the SePhaChARNS hypothesis remains to be proven; several experiments are under way; the complete circuit description is not available; pH values have not been determined for neurons; ADNFLE pathophysiology is not yet understood; and upregulation by nicotine plus a foot-in-the-door blocker remains only a theoretical possibility.
- Stated in the paper: SePhaChARNS probably does not explain withdrawal and may not explain heavy smoking in schizophrenia.
- Evident from the text: the review relies on unpublished or submitted data and narrative synthesis, with no systematic review methods or primary experimental methods reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
93 Not checked yet · 53 Own interpretation · 9 No basis given · 4 Supported · 3 Partly supported · 1 Supported so far · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This phenomenon probably does not require a circuit but arises from a change in presynaptic properties.”
What the sources say
- Partly supportedcites [5] R. Nashmi, C. Xiao, P. Deshpande, S. Mckinney, S. R. Grady, P. Whiteaker, Q. Huang, T. Mcclure-Begley, J. M. Lindstrom, C. Labarca, A. C. Collins, M. J. Marks, and H. A. Lester. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 27:8202–8218 (2007). sourceExperimental — accuracy not yet measured
In “Sensitization to nicotine at glutamatergic synapses suggests a mechanism for cognitive enhancement” (page not provided), the paper says nicotine-dependent potentiation in the perforant path appears explainable by action at a single synapse, with changes in presynaptic axons. It presents the link to cognitive sensitization as a possibility for further investigation, however, and says chronic nicotine may act through more complex circuit changes in other hippocampal regions. The claim overextends the single-synapse finding to cognitive function generally. (LLM, conf=0.85)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“This upregulation produces higher GABAergic SNr neuron firing rate, even in the absence of nicotine (5).”
What the sources say
- Supportedcites [5] R. Nashmi, C. Xiao, P. Deshpande, S. Mckinney, S. R. Grady, P. Whiteaker, Q. Huang, T. Mcclure-Begley, J. M. Lindstrom, C. Labarca, A. C. Collins, M. J. Marks, and H. A. Lester. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 27:8202–8218 (2007). source
The section on firing frequency in GABAergic neurons (page unavailable) reports significantly higher baseline firing in SNR GABAergic neurons from chronically nicotine-treated mice than in saline-treated controls, measured in the absence of nicotine. The authors say these functional effects correspond to the observed receptor upregulation. (LLM, conf=0.93)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Nicotine protects rodent DA neurons agonist toxin-induced cell loss (21–24), but these neuroprotective effects are absent in α4 nAChR knockout (KO) mice (22).”
What the sources say
- Supportedcites [22] R. E. Ryan, S. A. Ross, J. Drago, and R. E. Loiacono. Dose-related neuroprotective effects of chronic nicotine in 6-hydroxydopamine treated rats, and loss of neuroprotection in α4 nicotinic receptor subunit knockout mice. Br J Pharmacol. 132:1650–1656 (2001). source
The Discussion reports that acute nicotine attenuated methamphetamine-induced nigrostriatal damage in wild-type mice, but no significant neuroprotection was detected in α4 knockout mice. It notes a nonsignificant trend toward increased neuron survival, so “absent” refers to the lack of a significant protective effect. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In experiments conducted since ADNFLE was mapped in 1995, heterologous expression shows that ADNFLE receptors have a gain of function.”
What the sources say
- Partly supportedcites [30] D. Bertrand, F. Picard, S. Le Hellard, S. Weiland, I. Favre, H. Phillips, S. Bertrand, S. F. Berkovic, A. Malafosse, and J. Mulley. How mutations in the nAChRs can cause ADNFLE epilepsy. Epilepsia. 43(Suppl 5):112–122 (2002). sourceExperimental — accuracy not yet measured
The functional studies in Xenopus oocytes (Methods, p. 2) found increased ACh sensitivity across the four mutants. The Discussion (p. 11) says this common trait suggests a gain of receptor function; it does not establish unqualified gain of function for ADNFLE receptors as the claim states. (LLM, conf=0.84)
- Not checked yetcites [31] N. O. Rodrigues-Pinguet, T. J. Pinguet, A. Figl, H. A. Lester, and B. N. Cohen. Mutations linked to autosomal dominant nocturnal frontal lobe epilepsy affect allosteric Ca2+ activation of the α4β2 nicotinic acetylcholine receptor. Mol Pharmacol. 68:487–501 (2005). source
- Partly supportedcites [32] N. Rodrigues-Pinguet, L. Jia, M. Li, A. Figl, A. Klaassen, A. Truong, H.A. Lester, and B.N. Cohen. Five ADNFLE mutations reduce the Ca2+ dependence of the α4β2 acetylcholine response. J Physiol. 550:11–26 (2003). sourceExperimental — accuracy not yet measured
The Abstract reports heterologous expression of ADNFLE-mutant receptors in Xenopus oocytes, and the Discussion proposes that reduced Ca²⁺ sensitivity could produce a net gain of function under particular synaptic conditions. The expression experiments did not directly show a general gain of function; they showed reduced Ca²⁺-induced increases in the ACh response. (LLM, conf=0.86)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Upregulation does not require synaptic transmission or other diffusible extracellular signals.”
What the sources say
- Supportedcites [48] R. Nashmi, and H. Lester. Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation. Biochem Pharmacol. 74:1145–1154 (2007). source
The Discussion describes α4* receptor up-regulation as cell-autonomous: selective receptor activation was sufficient in nearly pure GABAergic cultures, without interactions with other cell types. The Results likewise state that contact with typical presynaptic input cells was unnecessary. Together, these support the claim that synaptic transmission or signals from other cells are not required in the cultured-neuron setting studied. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
In the paper
“Chronic exposure to nicotine increases α4* receptors on glutamatergic axons of the medial perforant path, which consists of projections from the entorhinal cortex to the dentate gyrus.”
What the sources say
- Not checked yetcites [5] R. Nashmi, C. Xiao, P. Deshpande, S. Mckinney, S. R. Grady, P. Whiteaker, Q. Huang, T. Mcclure-Begley, J. M. Lindstrom, C. Labarca, A. C. Collins, M. J. Marks, and H. A. Lester. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 27:8202–8218 (2007). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“In hippocampal slices from chronically treated animals, acute exposure to nicotine during tetanic stimuli lowers the threshold for induction of long-term potentiation in the medial perforant path.”
What the sources say
- Not checked yetcites [5] R. Nashmi, C. Xiao, P. Deshpande, S. Mckinney, S. R. Grady, P. Whiteaker, Q. Huang, T. Mcclure-Begley, J. M. Lindstrom, C. Labarca, A. C. Collins, M. J. Marks, and H. A. Lester. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 27:8202–8218 (2007). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“We find increased sensitivity both in the somata and in the synaptic terminals; the latter is assessed by recordings on the downstream target, SNc dopaminergic neurons.”
What the sources say
- Not checked yetcites C. Xiao and H. Lester, unpublished
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Our recent experiments show that five ADNFLE receptors have an additional common abnormality. The intracellular pool of mutant receptors is shifted toward the (α4)3(β2)2 stoichiometry.”
What the sources say
- Not checked yetcites C. Son, F. Moss, B. N. Cohen, H. A. Lester, submitted
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Treatment for 24 h with nicotine reverses this abnormality, bringing the stoichiometry to approximately WT levels (C. Son, F. Moss, B. N. Cohen, H. A. Lester, submitted).”
What the sources say
- Not checked yetcites C. Son, F. Moss, B. N. Cohen, H. A. Lester, submitted
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 41
- Probably not a substantial claim. 27
Every source the paper cites for this claim was checked and supports it.
In the paper
“Upregulation occurs in the GABAergic neurons of the ventral tegmental area (VTA), but not in the somata of the dopaminergic neurons which are postsynaptic targets of, and inhibited by, the GABAergic neurons.”
What the sources say
- Supportedcites [5] R. Nashmi, C. Xiao, P. Deshpande, S. Mckinney, S. R. Grady, P. Whiteaker, Q. Huang, T. Mcclure-Begley, J. M. Lindstrom, C. Labarca, A. C. Collins, M. J. Marks, and H. A. Lester. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 27:8202–8218 (2007). source
The Figure 4 caption (page unavailable) reports increased α4YFP fluorescence in VTA GABAergic neurons after chronic nicotine, with very little change in VTA dopaminergic neurons. The Discussion (page unavailable) says the dopaminergic measurements emphasize cell bodies and describes GABAergic inhibition of dopaminergic target neurons. (LLM, conf=0.92)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In consequence, SNc DA neurons from chronic nicotine-treated mice have a lower baseline firing rate and a lower incidence of burst firing.”
What the sources say
- Partly supportedcites [5] R. Nashmi, C. Xiao, P. Deshpande, S. Mckinney, S. R. Grady, P. Whiteaker, Q. Huang, T. Mcclure-Begley, J. M. Lindstrom, C. Labarca, A. C. Collins, M. J. Marks, and H. A. Lester. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 27:8202–8218 (2007). sourceExperimental — accuracy not yet measured
The section on firing frequency reports significantly lower baseline firing rates in SNC dopaminergic neurons from chronic nicotine-treated mice than in saline-treated mice. In “Possible mechanisms in substantia nigra” (page unavailable), decreased burst firing is proposed as a possible consequence in an intact animal, not reported as a measured lower incidence in the treated mice. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Experiments with cultures from α4-hypersensitive mice also show that upregulation occurs (a) at chronic nicotine concentrations that activate only α4* receptors, (b) in homotypic GABAergic cultures lacking their typical presynaptic partners, and (c) when tested with ACh concentrations that activate only the α4* receptors (48,49).”
What the sources say
- Supportedcites [48] R. Nashmi, and H. Lester. Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation. Biochem Pharmacol. 74:1145–1154 (2007). source
The Discussion states all three points: up-regulation at 10 nM nicotine that activated only α4* receptors, in homotypic GABAergic cultures lacking their typical presynaptic partners, and when tested with ACh concentrations that activated only α4* receptors. The Results also describe the selective nicotine exposure and low-dose ACh test. (LLM, conf=0.94)
- Not checked yetcites [49] A. Tapper, S. Mckinney, R. Nashmi, J. Schwarz, P. Deshpande, C. Labarca, P. Whiteaker, A. Collins, and H. Lester. Nicotine activation of α4* receptors: sufficient for reward, tolerance and sensitization. Science. 306:1029–1032 (2004). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
In the paper
“As a result, chronic nicotine increases both the baseline firing rate and the excitatory effect of nicotine in GABAergic neurons, while decreasing baseline firing rate and attenuating the excitatory effect of nicotine in dopaminergic neurons (5) (C. Xiao and H. Lester, unpublished).”
What the sources say
- Not checked yetcites [5] R. Nashmi, C. Xiao, P. Deshpande, S. Mckinney, S. R. Grady, P. Whiteaker, Q. Huang, T. Mcclure-Begley, J. M. Lindstrom, C. Labarca, A. C. Collins, M. J. Marks, and H. A. Lester. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 27:8202–8218 (2007). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“However, no such augmentation was observed when either the chronic nicotine exposure was omitted, or the acute exposure during the tetanus was omitted, or both (5).”
What the sources say
- Not checked yetcites [5] R. Nashmi, C. Xiao, P. Deshpande, S. Mckinney, S. R. Grady, P. Whiteaker, Q. Huang, T. Mcclure-Begley, J. M. Lindstrom, C. Labarca, A. C. Collins, M. J. Marks, and H. A. Lester. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 27:8202–8218 (2007). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Chronic exposure to nicotine produces new functional α4β2* receptors on all substantia nigra pars reticulata (SNr) GABAergic neurons, but not on their postsynaptic targets, the DA neurons of substantia nigra pars compacta (SNc).”
What the sources say
- Not checked yetcites [5] R. Nashmi, C. Xiao, P. Deshpande, S. Mckinney, S. R. Grady, P. Whiteaker, Q. Huang, T. Mcclure-Begley, J. M. Lindstrom, C. Labarca, A. C. Collins, M. J. Marks, and H. A. Lester. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 27:8202–8218 (2007). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“and that increases in inhibition could provide an explanation for tolerance to the chronic effects of nicotine (5).”
What the sources say
- Not checked yetcites [5] R. Nashmi, C. Xiao, P. Deshpande, S. Mckinney, S. R. Grady, P. Whiteaker, Q. Huang, T. Mcclure-Begley, J. M. Lindstrom, C. Labarca, A. C. Collins, M. J. Marks, and H. A. Lester. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 27:8202–8218 (2007). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“We now know that α4β2* receptors (* = IUPHAR nomenclature, “other subunits may be present”) are selectively upregulated (a partial reason for the initial “Se” in SePhaChARNS) but that other subtypes are also upregulated (3);”
What the sources say
- Not checked yetcites [3] H. N. Nguyen, B. A. Rasmussen, and D. C. Perry. Subtype-selective up-regulation by chronic nicotine of high-affinity nicotinic receptors in rat brain demonstrated by receptor autoradiography. J Pharmacol Exp Ther. 307:1090–1097 (2003). source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Nicotine makes neither interaction with the muscle receptor (45,46).”
What the sources say
- Not checked yetcites [45] D. L. Beene, G. S. Brandt, W. Zhong, N. M. Zacharias, H. A. Lester, and D. A. Dougherty. Cation-π interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine. Biochemistry. 41:10262–10269 (2002). source
- Not checked yetcites [46] A. L. Cashin, E. J. Petersson, H. A. Lester, and D. A. Dougherty. Using physical chemistry to differentiate nicotinic from cholinergic agonists at the nicotinic acetylcholine receptor. J Am Chem Soc. 127:350–356 (2005). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This implies that nicotine can also enter the endoplasmic reticulum and other organelles.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“If ACh survived for several hours near neurons (which is not the case), it too would produce SePhaChARNS.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“However, the in vitro effect of nicotine brings partial rationalization to its in vivo effect and suggests new clues about the pathophysiology.”
What the sources say
- Not checked yetcites C. Son, F. Moss, B. N. Cohen, H. A. Lester, submitted
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Quaternary amines with substantial hydrophobic substituents also display detectable membrane permeability; this is revealed in the literature on blockers of voltage-gated ion channels.”
What the sources say
- Not checked yetcites [40] C. M. Armstrong. Interaction of tetraethylamonium ion derivatives with the potassium channels of giant axons. J. Gen. Physiol. 58:413–437 (1971). source
- Not checked yetcites [41] M. Taglialatela, A. M. Vandongen, J. A. Drewe, R. H. Joho, A. M. Brown, and G. E. Kirsch. Patterns of internal and external tetraethylammonium block in four homologous K+ channels. Mol Pharmacol. 40:299–307 (1991). source
- Not checked yetcites [42] G. K. Wang, C. Quan, M. Vladimirov, W. M. Mok, and J. G. Thalhammer. Quaternary ammonium derivative of lidocaine as a long-acting local anesthetic. Anesthesiology. 83:1293–1301 (1995). source
- Not checked yetcites [43] T. K. Lim, B. A. Macleod, C. R. Ries, and S. K. Schwarz. The quaternary lidocaine derivative, QX-314, produces long-lasting local anesthesia in animal models in vivo. Anesthesiology. 107:305–311 (2007). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“These effects on dopaminergic terminals extend and confirm other reports that chronic nicotine increases nicotine-induced dopamine release (25,26) and upregulates receptors in striatum (5).”
What the sources say
- Not checked yetcites [25] D. L. Marshall, P. H. Redfern, and S. Wonnacott. Presynaptic nicotinic modulation of dopamine release in the three ascending pathways studied by in vivo microdialysis: comparison of naive and chronic nicotine-treated rats. J Neurochem. 68:1511–1519 (1997). source
- Not checked yetcites [26] N. P. Visanji, S. N. Mitchell, M. J. O'neill, and S. Duty. Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and α6 and β3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat. Neuropharmacology. 50:36–46 (2006). source
- Not checked yetcites [5] R. Nashmi, C. Xiao, P. Deshpande, S. Mckinney, S. R. Grady, P. Whiteaker, Q. Huang, T. Mcclure-Begley, J. M. Lindstrom, C. Labarca, A. C. Collins, M. J. Marks, and H. A. Lester. Chronic nicotine cell specifically upregulates functional α4* nicotinic receptors: basis for both tolerance in midbrain and enhanced long-term potentiation in perforant path. J Neurosci. 27:8202–8218 (2007). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Nicotine is metabolized only by liver enzymes and disappears from blood with a half-life of ~120 min (35).”
What the sources say
- Not checked yetcites [35] S. G. Matta, D. J. Balfour, N. L. Benowitz, R. T. Boyd, J. J. Buccafusco, A. R. Caggiula, C. R. Craig, A. C. Collins, M. I. Damaj, E. C. Donny, P. S. Gardiner, S. R. Grady, U. Heberlein, S. S. Leonard, E. D. Levin, R. J. Lukas, A. Markou, M. J. Marks, S. E. Mccallum, N. Parameswaran, K. A. Perkins, M. R. Picciotto, M. Quik, J. E. Rose, A. Rothenfluh, W. R. Schafer, I. P. Stolerman, R. F. Tyndale, J. M. Wehner, and J. M. Zirger. Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl). 190:269–319 (2007). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The EC50 for nicotine at (α4)2(β2)3 neuronal receptors is ~1 μM; at (α1)2β1γδ muscle receptors, ~ 400 μM.”
What the sources say
- Not checked yetcites [44] X. X. Xiu, N. Puskar, J. Shanata, H. A. Lester, and D. A. Dougherty. Nicotine binding to brain receptors requires a strong cation-π interaction Nature. (in press) (2009). source
- Not checked yetcites [45] D. L. Beene, G. S. Brandt, W. Zhong, N. M. Zacharias, H. A. Lester, and D. A. Dougherty. Cation-π interactions in ligand recognition by serotonergic (5-HT3A) and nicotinic acetylcholine receptors: the anomalous binding properties of nicotine. Biochemistry. 41:10262–10269 (2002). source
- Not checked yetcites [46] A. L. Cashin, E. J. Petersson, H. A. Lester, and D. A. Dougherty. Using physical chemistry to differentiate nicotinic from cholinergic agonists at the nicotinic acetylcholine receptor. J Am Chem Soc. 127:350–356 (2005). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Nicotine is quite effective as a smoked drug because it permeates at least six membranes, in the lungs and capillary walls, within a few seconds of inhalation.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, because agonists open the channel, they allow access to many more conformational states than do antagonists; and if these new states have high affinity, then SePhaChARNS is strengthened, whether or not the new conformational states have open channels.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Unsurprisingly, hexamethonium, mecamylamine, or decamethonium by themselves do not produce appreciable up-regulation (54,65).”
What the sources say
- Not checked yetcites [54] T. Darsow, T. K. Booker, J. C. Pina-Crespo, and S. F. Heinemann. Exocytic trafficking is required for nicotine-induced up-regulation of α4β2 nicotinic acetylcholine receptors. J Biol Chem. 280:18311–18320 (2005). source
- Not checked yetcites [65] P. Whiteaker, C. G. Sharples, and S. Wonnacott. Agonist-induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol Pharmacol. 53:950–962 (1998). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“(2) It must be present at concentrations greater than its equilibrium dissociation constant for the nAChR subtype (including the particular stoichiometry) that it will chaperone.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“In fact, neither hexamethonium (61) nor chlorisondamine (62), two well-studied channel blockers at nAChRs, are foot-in-the door blockers at high-sensitivity α4β2 receptors;”
What the sources say
- Not checked yetcites [61] P. Charnet, C. Labarca, B. N. Cohen, N. Davidson, H. A. Lester, and G. Pilar. Pharmacological and kinetic properties of α4β2 neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Physiol. 450:375–394 (1992). source
- Not checked yetcites [62] C. A. Briggs, E. J. Gubbins, M. J. Marks, C. B. Putman, R. Thimmapaya, M. D. Meyer, and C. S. Surowy. Untranslated region-dependent exclusive expression of high-sensitivity subforms of α4β2 and α3β2 nicotinic acetylcholine receptors. Mol Pharmacol. 70:227–240 (2006). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These differences show how nicotine can activate and upregulate (α4)2(β2)3 receptors but have minimal effect on muscle receptors.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In the absence of energy input, any reversible chemical interaction eventually reaches its state of lowest free energy, if the kinetic barriers are low enough to allow access to these states on the time scale of nicotine’s presence.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The upregulated receptors are apparently shifted toward the high nicotine affinity, high-sensitivity (α4)2(β2)3 stoichiometry, at the expense of the lower-sensitivity (α4)3(β2)2 stoichiometry.”
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“(3) It should bind at one or more subunit interfaces in the pentameric complex, so that it can stabilize the assembled rather than unassembled receptor.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Several studies suggest that the two forms differ in subunit composition: the high- and low-sensitivity forms would consist of the (α4)2(β2)3 and (α4)3(β2)2 pentamers, respectively (74–76).”
What the sources say
- Not checked yetcites [74] R. Zwart, and H. P. Vijverberg. Four pharmacologically distinct subtypes of α4β2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes. Mol Pharmacol. 54:1124–1131 (1998). source
- Not checked yetcites [75] Y. Zhou, M. E. Nelson, A. Kuryatov, C. Choi, J. Cooper, and J. Lindstrom. Human α4β2 acetylcholine receptors formed from linked subunits. J Neurosci. 23:9004–9015 (2003). source
- Not checked yetcites [76] M. E. Nelson, A. Kuryatov, C. H. Choi, Y. Zhou, and J. Lindstrom. Alternate stoichiometries of α4β2 nicotinic acetylcholine receptors. Mol Pharmacol. 63:332–341 (2003). source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These observations agree well with the SePhaChARNS mechanism, which makes no explicit statements about agonists vs antagonists.”
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Descriptions that may be essentially equivalent to SePhaChARNS are the statements that nicotine acts as a “maturational enhancer” or a “novel slow stabilizer” for α4β2* receptors (39,50–52).”
What the sources say
- Not checked yetcites [39] A. Kuryatov, J. Luo, J. Cooper, and J. Lindstrom. Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors. Mol Pharmacol. 68:1839–1851 (2005). source
- Not checked yetcites [50] J. Sallette, S. Pons, A. Devillers-Thiery, M. Soudant, L. Prado De Carvalho, J. P. Changeux, and P. J. Corringer. Nicotine upregulates its own receptors through enhanced intracellular maturation. Neuron. 46:595–607 (2005). source
- Not checked yetcites [51] P. Tumkosit, A. Kuryatov, J. Luo, and J. Lindstrom. β3 subunits promote expression and nicotine-induced up-regulation of human nicotinic α6* nicotinic acetylcholine receptors expressed in transfected cell lines. Mol Pharmacol. 70:1358–1368 (2006). source
- Not checked yetcites [52] Y. F. Vallejo, B. Buisson, D. Bertrand, and W. N. Green. Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J Neurosci. 25:5563–5572 (2005). source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“Mecamylamine, a frequently used nonspecific nAChR channel blocker, lacks foot-in-the-door properties at ganglionic nAChRs (64) and has not been evaluated for such properties at α4β2 receptors.”
What the sources say
- Not checked yetcites [64] A. M. Gurney, and H. P. Rang. The channel-blocking action of methonium compounds on rat submandibular ganglion cells. Br. J. Pharmacol. 82:623–642 (1984). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Selective nicotine binding to α4* nAChRs is sufficient for α4* receptor upregulation when α4* receptors are heterologously expressed in mammalian cell lines, as well as in almost pure cultures of GABAergic ventral midbrain neurons (48).”
What the sources say
- Not checked yetcites [48] R. Nashmi, and H. Lester. Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation. Biochem Pharmacol. 74:1145–1154 (2007). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Here are the requirements for an effective pharmacological chaperone for nAChRs. (1) The drug must penetrate to the lumen of the endoplasmic reticulum.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper may give no reason why it holds.
In the paper
“Upregulation induced in animal models and transfected cells by chronic nicotine is certainly not transcriptional and is probably post-translational (47).”
What the sources say
- Not checked yetcites [47] J. R. Pauly, M. J. Marks, S. F. Robinson, J. L. Van De Kamp, and A. C. Collins. Chronic nicotine and mecamylamine treatment increase brain nicotinic receptor binding without changing α4 or β2 mRNA levels. J Pharmacol Exp Ther. 278:361–369 (1996). source
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“Nicotine accumulates within cells, so that the apparent “intracellular volume” occupied by nicotine is six- to eightfold greater than the total intracellular volume measured, for instance, by inulin exclusion.”
What the sources say
- Not checked yetcites [77] J. W. Putney Jr., and J. F. Borzelleca. On the mechanisms of [14C]nicotine distribution in rat submaxillary gland in vitro. J Pharmacol Exp Ther. 178:180–191 (1971). source
- Not checked yetcites [78] A. Roos, and W. F. Boron. Intracellular pH. Physiol. Rev. 61:296–434 (1981). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“Exocytosis is required for upregulation, presumably because exocytosis is downstream from SePhaChARNS (53).”
What the sources say
- Not checked yetcites [53] J. Xu, Y. Zhu, and S. F. Heinemann. Identification of sequence motifs that target neuronal nicotinic receptors to dendrites and axons. J Neurosci. 26:9780–9793 (2006). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: unclear — It is unclear why the paper says it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A pH of 6.5, roughly 0.5 pH unit lower than the cytoplasmic pH, implies a concentration of nicotine threefold higher in the organelle than in the cytoplasm; at pH 5.5, the ratio is 30.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Human α4 harboring a Ser247Phe mutation (at the M2 6′ position) renders the channel nonfunctional in HEK tsA201 cells, and yet chronic nicotine induces robust upregulation of the receptor in this clonal cell line (39).”
What the sources say
- Not checked yetcites [39] A. Kuryatov, J. Luo, J. Cooper, and J. Lindstrom. Nicotine acts as a pharmacological chaperone to up-regulate human α4β2 acetylcholine receptors. Mol Pharmacol. 68:1839–1851 (2005). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The most thoroughly investigated and replicated finding to date is the association with rs16969968, in CHRNA5 (91).”
What the sources say
- Not checked yetcites [91] S. F. Saccone, A. L. Hinrichs, N. L. Saccone, G. A. Chase, K. Konvicka, P. A. Madden, N. Breslau, E. O. Johnson, D. Hatsukami, O. Pomerleau, G. E. Swan, A. M. Goate, J. Rutter, S. Bertelsen, L. Fox, D. Fugman, N. G. Martin, G. W. Montgomery, J. C. Wang, D. G. Ballinger, J. P. Rice, and L. J. Bierut. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Human Molecular Genetics. 16:36–49 (2007). source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, if their assembly and function is approximately normal, then it is a strong conclusion that, in the presence of smoked nicotine, receptors are primarily in a desensitized state before they reach the cell surface.”
boostedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: The assembly and function of receptors within the secretory pathway is approximately normal.
In the paper
“In the ion channel field, one relevant example is the use of small-molecule proteostasis regulators to stabilize the misfolding-prone ΔF508 mutant of the cystic fibrosis transmembrane conductance regulator (83).”
What the sources say
- Not checked yetcites [83] Www.Clinicaltrials.Gov . [cited.
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“A second signal in the CHRNA5/A3/B4 cluster is tagged by SNP rs578776; it is strongly associated with nicotine dependence and has a low correlation with rs16969968 (r2 = 0.18), indicating that it represents a statistically independent signal (90,91).”
What the sources say
- Not checked yetcites [90] L. J. Bierut, P. A. Madden, N. Breslau, E. O. Johnson, D. Hatsukami, O. F. Pomerleau, G. E. Swan, J. Rutter, S. Bertelsen, L. Fox, D. Fugman, A. M. Goate, A. L. Hinrichs, K. Konvicka, N. G. Martin, G. W. Montgomery, N. L. Saccone, S. F. Saccone, J. C. Wang, G. A. Chase, J. P. Rice, and D. G. Ballinger. Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet. 16:24–35 (2007). source
- Not checked yetcites [91] S. F. Saccone, A. L. Hinrichs, N. L. Saccone, G. A. Chase, K. Konvicka, P. A. Madden, N. Breslau, E. O. Johnson, D. Hatsukami, O. Pomerleau, G. E. Swan, A. M. Goate, J. Rutter, S. Bertelsen, L. Fox, D. Fugman, N. G. Martin, G. W. Montgomery, J. C. Wang, D. G. Ballinger, J. P. Rice, and L. J. Bierut. Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Human Molecular Genetics. 16:36–49 (2007). source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Thus, in one view, stabilization of high-affinity nicotinic receptors by chronic nicotine is a thermodynamic necessity (48).”
What the sources say
- Not checked yetcites [48] R. Nashmi, and H. Lester. Cell autonomy, receptor autonomy, and thermodynamics in nicotine receptor up-regulation. Biochem Pharmacol. 74:1145–1154 (2007). source
hedgeddirect- Asserted: fails — The authors may not put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The authors may not put it forward as true.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Second, SePhaChARNS does not explicitly include nicotine-evoked changes in endocytosis or exocytosis.”
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“At present, we believe that α4β2 receptors, in the absence of additional subunits, may be more amenable to SePhaChARNS than other subtypes, for the constellation of reasons just given; but this impression may simply derive from our more complete knowledge of this subtype.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The noncoding mutations, such as rs578776, could affect the level of expression of the α5 protein, therefore affect the proportion of α4β2* receptors that are α4β2α5* receptors, and thus also affect chaperoning.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Knockout mice for the α5 subunit display a reduction in the somatic but not affective signs of nicotine withdrawal, probably arising from autonomic ganglia and other peripheral α3* nAChRs (14).”
What the sources say
- Not checked yetcites [14] K. J. Jackson, B. R. Martin, J. P. Changeux, and M. I. Damaj. Differential role of nicotinic acetylcholine receptor subunits in physical and affective nicotine withdrawal signs. J Pharmacol Exp Ther. 325:302–312 (2008). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Lynx1KO mice demonstrate cognitive enhancements and neurological changes (116), features associated with hyperactive nAChRs, including improved learning, increased intracellular Ca2+ in response to nicotine treatment, less receptor desensitization, and heightened nicotine sensitivity.”
What the sources say
- Not checked yetcites [116] J. M. Miwa, T. R. Stevens, S. L. King, B. J. Caldarone, I. Ibanez-Tallon, C. Xiao, R. M. Fitzsimonds, C. Pavlides, H. A. Lester, M. R. Picciotto, and N. Heintz. The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo. Neuron. 51:587–600 (2006). source
boostedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“In the presence of lynx1, α4β2 nAChRs are up to 20-fold less sensitive to ACh in a Xenopus oocyte expression system, desensitize more rapidly, and recover more slowly from desensitization (114).”
What the sources say
- Not checked yetcites [114] I. Ibanez-Tallon, J. M. Miwa, H. L. Wang, N. C. Adams, G. W. Crabtree, S. M. Sine, and N. Heintz. Novel modulation of neuronal nicotinic acetylcholine receptors by association with the endogenous prototoxin lynx1. Neuron. 33:893–903 (2002). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“SLURP1 differs from lynx1 in that SLURP1 is expressed in the periphery, not in neurons, and is not GPI anchored, but is secreted out of the cell (121,122).”
What the sources say
- Not checked yetcites [121] M. Skok, R. Grailhe, and J. P. Changeux. Nicotinic receptors regulate B lymphocyte activation and immune response. Eur J Pharmacol. 517:246–251 (2005). source
- Not checked yetcites [122] M. V. Skok, R. Grailhe, F. Agenes, and J. P. Changeux. The role of nicotinic receptors in B-lymphocyte development and activation. Life Sci. 80:2334–2336 (2007). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
In the paper
“For example, SLURP-1 is mutated in Mal de Meleda (120).”
What the sources say
- Not checked yetcites [120] F. Chimienti, R. C. Hogg, L. Plantard, C. Lehmann, N. Brakch, J. Fischer, M. Huber, D. Bertrand, and D. Hohl. Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda. Hum Mol Genet. 12:3017–3024 (2003). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In lung, lynx1 is co-expressed with nAChRs (125).”
What the sources say
- Not checked yetcites [125] H. S. Sekhon, P. Song, Y. Jia, J. Lindstrom, and E. R. Spindel. Expression of lynx1 in developing lung and its modulation by prenatal nicotine exposure. Cell Tissue Res. 320:287–297 (2005). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In other words, we think it is possible that a key lynx–nAChR interaction occurs during receptor biosynthesis and maturation, in addition to acute nicotine–receptor interactions at the surface membrane.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“Aging lynx1 KO mice undergo a striatal degeneration which is exacerbated by nicotine and ameliorated by crossing lynx1KO mice with those lacking α7 nAChRs, indicating that both α7 and α4β2-type nAChRs may be important targets of lynx1 genes (116).”
What the sources say
- Not checked yetcites [116] J. M. Miwa, T. R. Stevens, S. L. King, B. J. Caldarone, I. Ibanez-Tallon, C. Xiao, R. M. Fitzsimonds, C. Pavlides, H. A. Lester, M. R. Picciotto, and N. Heintz. The prototoxin lynx1 acts on nicotinic acetylcholine receptors to balance neuronal activity and survival in vivo. Neuron. 51:587–600 (2006). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“while others report an increased risk of lung cancer even in nonsmokers, suggesting the possibility of a direct effect on lung cancer vulnerability (101,104).”
What the sources say
- Not checked yetcites [101] R. J. Hung, J. D. Mckay, V. Gaborieau, P. Boffetta, M. Hashibe, D. Zaridze, A. Mukeria, N. Szeszenia-Dabrowska, J. Lissowska, P. Rudnai, E. Fabianova, D. Mates, V. Bencko, L. Foretova, V. Janout, C. Chen, G. Goodman, J. K. Field, T. Liloglou, G. Xinarianos, A. Cassidy, J. Mclaughlin, G. Liu, S. Narod, H. E. Krokan, F. Skorpen, M. B. Elvestad, K. Hveem, L. Vatten, J. Linseisen, F. Clavel-Chapelon, P. Vineis, H. B. Bueno-De-Mesquita, E. Lund, C. Martinez, S. Bingham, T. Rasmuson, P. Hainaut, E. Riboli, W. Ahrens, S. Benhamou, P. Lagiou, D. Trichopoulos, I. Holcatova, F. Merletti, K. Kjaerheim, A source
- Not checked yetcites [104] C. I. Amos, X. Wu, P. Broderick, I. P. Gorlov, J. Gu, T. Eisen, Q. Dong, Q. Zhang, X. Gu, J. Vijayakrishnan, K. Sullivan, A. Matakidou, Y. Wang, G. Mills, K. Doheny, Y. Y. Tsai, W. V. Chen, S. Shete, M. R. Spitz, and R. S. Houlston. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 40:616–622 (2008). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It is also possible that SePhaChARNS could be manipulated by drugs that modify protein chaperones.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
In the paper
“some indicate that the association could be explained through an indirect effect on risk for smoking (96)”
What the sources say
- Not checked yetcites [96] T. E. Thorgeirsson, F. Geller, P. Sulem, T. Rafnar, A. Wiste, K. P. Magnusson, A. Manolescu, G. Thorleifsson, H. Stefansson, A. Ingason, S. N. Stacey, J. T. Bergthorsson, S. Thorlacius, J. Gudmundsson, T. Jonsson, M. Jakobsdottir, J. Saemundsdottir, O. Olafsdottir, L. J. Gudmundsson, G. Bjornsdottir, K. Kristjansson, H. Skuladottir, H. J. Isaksson, T. Gudbjartsson, G. T. Jones, T. Mueller, A. Gottsater, A. Flex, K. K. Aben, F. De Vegt, P. F. Mulders, D. Isla, M. J. Vidal, L. Asin, B. Saez, L. Murillo, T. Blondal, H. Kolbeinsson, J. G. Stefansson, I. Hansdottir, V. Runarsdottir, R. Pola, B. Lin source
hedgedconditional- Asserted: fails — The authors may not put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The authors may not put it forward as true. The paper’s conclusions may not depend on it.
None of the sources cited for this claim have been checked yet.
In the paper
“Bronchial epithelium, squamous cell lung carcinoma, non-small-cell lung cancers, and BEP2D cells express α5 subunits (108–110); but their partner subunits and functional states are not known.”
What the sources say
- Not checked yetcites [108] A. D. Maus, E. F. Pereira, P. I. Karachunski, R. M. Horton, D. Navaneetham, K. Macklin, W. S. Cortes, E. X. Albuquerque, and B. M. Conti-Fine. Human and rodent bronchial epithelial cells express functional nicotinic acetylcholine receptors. Mol Pharmacol. 54:779–788 (1998). source
- Not checked yetcites [109] J. Arredondo, A. I. Chernyavsky, and S. A. Grando. The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells. J Cancer Res Clin Oncol. 132:653–663 (2006). source
- Not checked yetcites [110] P. Song, H. S. Sekhon, X. W. Fu, M. Maier, Y. Jia, J. Duan, B. J. Proskosil, C. Gravett, J. Lindstrom, G. P. Mark, S. Saha, and E. R. Spindel. Activated cholinergic signaling provides a target in squamous cell lung carcinoma. Cancer Res. 68:4693–4700 (2008). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Other studies on α5 knockout mice show changes in both presynaptic and somatodendritic nAChR responses (111).”
What the sources say
- Not checked yetcites [111] H. Fischer, A. Orr-Urtreger, L. W. Role, and S. Huck. Selective deletion of the α5 subunit differentially affects somatic-dendritic versus axonally targeted nicotinic ACh receptors in mouse. J Physiol. 563:119–137 (2005). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The rs16969968, coding-region mutation, in the M3–M4 cytoplasmic loop, could interact with ERAD machinery to alter chaperoning.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“A modest and obvious extension of this idea is that lynx may bind to non-agonist interfaces, such as the α4–α4 interface in (α4)3(β2)2 receptors, or the allosterically important α4–α5 interface if the complex includes an α5 subunit (113,126).”
What the sources say
- Not checked yetcites [113] A. Kuryatov, J. Onksen, and J. Lindstrom. Roles of accessory subunits in α4β2α5 nicotinic receptors. Mol Pharmacol. 74:132–143 (2008). source
- Not checked yetcites [126] S. M. Kassam, P. M. Herman, N. M. Goodfellow, N. C. Alves, and E. K. Lambe. Developmental excitation of corticothalamic neurons by nicotinic acetylcholine receptors. J Neurosci. 28:8756–8764 (2008). source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, one may best discover drugs that affect SePhaChARNS by studying events in the ER.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: fails — It may be too vague to check against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may be too vague to check against evidence.
None of the sources cited for this claim have been checked yet.
In the paper
“SLURPs enhance this process (123) as well as oral and lung cancer cell proliferation (124).”
What the sources say
- Not checked yetcites [123] J. Arredondo, A. I. Chernyavsky, R. J. Webber, and S. A. Grando. Biological effects of SLURP-1 on human keratinocytes. J Invest Dermatol. 125:1236–1241 (2005). source
- Not checked yetcites [124] J. Arredondo, A. I. Chernyavsky, and S. A. Grando. SLURP-1 and -2 in normal, immortalized and malignant oral keratinocytes. Life Sci. 80:2243–2247 (2007). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Furthermore, they suggest that lynx proteins oppose some of the effects of chronic nicotine exposure, and have a desensitizing influence on nAChRs.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The authors state this as an assumption.
All drugs in Table I may be assumed to have pKa values between 7.4 and 8.
“All drugs in this list may be assumed to have pKa values between 7.4 and 8.”
The paper relies on this without support.
The first steps in assembly and synthesis of nAChRs occur in the endoplasmic reticulum, which is roughly neutral.
“The first steps in assembly and synthesis of nAChRs occur in the endoplasmic reticulum (ER) itself, which is roughly neutral.”
The authors state this as an assumption.
The assembly and function of receptors within the secretory pathway is approximately normal.
“if their assembly and function is approximately normal”
The authors state this as an assumption.
Surface receptors recover from desensitization within a matter of minutes after exposure to extracellular nicotine.
“Presumably, they recover from desensitization within a matter of minutes.”
The authors state this as an assumption.
Subunit composition controls the affinity for nicotine, the extent of interaction with the ERAD machinery, the extent to which desensitization makes additional states available, and the extent and stability of additional stoichiometries.
“the subunit composition presumably controls the affinity for nicotine, the extent of interaction with the ERAD machinery, the extent to which desensitization makes many additional states available, and the extent and stability of additional stoichiometries”
The paper relies on this without support.
2-[F18]fluoro-A-85380 binds well to α4β2* and α6* nAChRs.
“The positron emission tomography (PET) ligand, 2-[F18]fluoro-A-85380, binds well to α4β2* and to α6* nAChRs.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Nicotine appears to act intracellularly as a selective pharmacological chaperone of acetylcholine receptor (Lester et al. 2009).”
From Short- and Long-Term Consequences of Nicotine Exposure during Adolescence for Prefrontal Cortex Neuronal Network Function (2012) · cites this paper as Lester et al. 2009
The cited source says what the claim attributes to it.
In the citing paper
“The up-regulation of a4b2 nAChRs by chronic nicotine treatment has been replicated many times in numerous systems—transfected cell lines, neurons in culture, brain slices, and smokers’ brains (Wonnacott 1990; Fu et al. 2009; Lester et al. 2009; Marks et al. 2011; Miwa et al. 2011).”
From Short- and Long-Term Consequences of Nicotine Exposure during Adolescence for Prefrontal Cortex Neuronal Network Function (2012) · cites this paper as Lester et al. 2009
The cited source says what the claim attributes to it.
In the citing paper
“It stabilizes nAChRs during assembly and maturation and this stabilization is most pronounced for the highest-affinity nAChR containing α4β2 subunits.”
From Short- and Long-Term Consequences of Nicotine Exposure during Adolescence for Prefrontal Cortex Neuronal Network Function (2012) · cites this paper as Lester et al. 2009
In the citing paper
“Relevant to the understanding of the neuroadaptations produced by nicotine is the fact that nAChR upregulation differs among receptor subtypes, varies among brain regions for the same subtype, and even depends on the contingency of nicotine administration [9, 90, 93].”
From Mechanistic insights into nicotine withdrawal (2011) · cites this paper as [90]
In the citing paper
“Nicotine concentrations are elevated within ERGIC, TG/TGN, and secretory vesicles via acid trapping (Lester et al., 2009).”
From Nicotine up-regulates α4β2 nicotinic receptors and ER exit sites via stoichiometry-dependent chaperoning (2011) · cites this paper as Lester et al., 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Abstract
“Even the lowest log P value, −0.4 for the competitive antagonist DHβE (Table 1), would allow it to penetrate eventually.”
§ Abstract
“X log P Dihydro-β˜-erythroidine −0.5 Cytisine −0.3”
Citations
Cites
Roos, A., & Boron, W. F. (1981) · Physiological Reviews · doi:10.1152/physrev.1981.61.2.296 · Cited by 2,511
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
Thorgeirsson, T. E., Geller, F., Sulem, P., Rafnar, T., Wiste, A., Magnusson, K. P., Manolescu, A., Thorleifsson, G., Stefansson, H., Ingason, A., et al. (2008) · Nature · doi:10.1038/nature06846 · Cited by 1,523
Amos, C. I., Wu, X., Broderick, P., Gorlov, I. P., Gu, J., Eisen, T., Dong, Q., Zhang, Q., Gu, X., Vijayakrishnan, J., et al. (2008) · Nature Genetics · doi:10.1038/ng.109 · Cited by 1,310
Hung, R. J., McKay, J. D., Gaborieau, V., Boffetta, P., Hashibe, M., Zaridze, D., Mukeria, A., Szeszenia-Dabrowska, N., Lissowska, J., Rudnai, P., et al. (2008) · Nature · doi:10.1038/nature06885 · Cited by 1,275
Steinlein, O. K., Mulley, J. C., Propping, P., Wallace, R. H., Phillips, H. A., Sutherland, G. R., Scheffer, I. E., & Berkovic, S. F. (1995) · Nature Genetics · doi:10.1038/ng1095-201 · Cited by 1,134
Interaction of Tetraethylammonium Ion Derivatives with the Potassium Channels of Giant Axons
Armstrong, C. M. (1971) · The Journal of General Physiology · doi:10.1085/jgp.58.4.413 · Cited by 929
Brain nicotinic acetylcholine receptors: native subtypes and their relevance
Gotti, C., Zoli, M., & Clementi, F. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.07.004 · Cited by 882
Saccone, S. F., Hinrichs, A. L., Saccone, N. L., Chase, G. A., Konvicka, K., Madden, P. A. F., Breslau, N., Johnson, E. O., Hatsukami, D., Pomerleau, O., et al. (2007) · Human Molecular Genetics · doi:10.1093/hmg/ddl438 · Cited by 850 · cited 10×
“A second signal in the CHRNA5/A3/B4 cluster is tagged by SNP rs578776; it is strongly associated with nicotine dependence and has a low correlation with rs16969968 (r2= 0.18), indicating that it represents a statistically independent signal (90,91).”
BackgroundInfluentialSelf-citationGuidelines on nicotine dose selection for in vivo research
Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., Craig, C. R., Collins, A. C., Damaj, M. I., Donny, E. C., et al. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0441-0 · Cited by 824
Research works printed but not linked: 2
- P. Liu, H. G. Vikis, D. Wang, Y. Lu, Y. Wang, A. G. Schwartz, S. M. Pinney, P. Yang, M. De Andrade, G. M. Petersen, J. S. Wiest, P. R. Fain, A. Gazdar, C. Gaba, H. Rothschild, D. Mandal, T. Coons, J. Lee, E. Kupert, D. Seminara, J. Minna, J. E. Bailey-Wilson, X. Wu, M. R. Spitz, T. Eisen, R. S. Houlston, C. I. Amos, M. W. Anderson, and M. You. Familial aggregation of common sequence variants on 15q24–25.1 in lung cancer. J Natl Cancer Inst. 100:1326–1330 (2008). · DOI · Paper page
- C. I. Amos, X. Wu, P. Broderick, I. P. Gorlov, J. Gu, T. Eisen, Q. Dong, Q. Zhang, X. Gu, J. Vijayakrishnan, K. Sullivan, A. Matakidou, Y. Wang, G. Mills, K. Doheny, Y. Y. Tsai, W. V. Chen, S. Shete, M. R. Spitz, and R. S. Houlston. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet. 40:616–622 (2008). · DOI · Paper page
Cited by
Sorted by citations
Items 101–164 of 164
Shahoei, R., & Tajkhorshid, E. (2020) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.9b10092 · Cited by 18
Molecular mechanisms of α7-nAchR-mediated anti-inflammatory effects
Youssef, M. E., Moustafa, Y. M., & Abdelrazek, H. M. A. (2021) · Indian Journal of Physiology and Pharmacology · doi:10.25259/ijpp_129_2020 · Cited by 16
Metaxas, A., Al‐Hasani, R., Farshim, P. P., Tubby, K. C., Berwick, A., Ledent, C. A., Hourani, S. M. O., Kitchen, I., & Bailey, A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.023 · Cited by 15
“nicotinic subunit chaperoning have been implicated in the upregulation of α4β2* nAChRs (Govind et al., 2009; Govind et al., 2012; Lester et al., 2009), similar nicotine-induced alterations do not mediate the upregulation of homopentameric α7 nAChRs.”
BackgroundPubill, D., Garcia‐Ratés, S., Camarasa, J., & Escubedo, E. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.11.008 · Cited by 15
“Such upregulation occurs at a post-translational level and several mechanisms have been proposed to explain it, including a chaperone-like maturation enhancing effect of nicotine (Lester et al., 2009; Kuryatov et al., 2005; Sallette et al., 2005; Srinivasan et al., 2011”
BackgroundHamouda, A. K., Bautista, M. R., Akinola, L. S., Alkhlaif, Y., Jackson, A. B., Carper, M., Toma, W. B., Garai, S., Chen, Y.-C., Thakur, G. A., et al. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108568 · Cited by 15
Smith, A. M., Pivavarchyk, M., Wooters, T. E., Zhang, Z., Zheng, G., McIntosh, J. M., Crooks, P. A., Bardo, M. T., & Dwoskin, L. P. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.03.018 · Cited by 15
“Repeated nicotine treatment alters on nAChR stoichiometry, conformation and composition [19], and long term exposure to nicotine alters nAChR maturation by increasing nAChR subunit oligomerization and folding [17,48].”
BackgroundFilchakova, O., & McIntosh, J. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064655 · Cited by 15
“Nicotine exposure causes an upregulation of nicotinic AChRs in brain as well as in vitro, and a possible explanation of this effect is through the chaperoning by nicotine [90], [91], [92].”
BackgroundMolecular insights into the α6β4 nicotinic acetylcholine receptor function and ligand recognition
Su, J., Yu, Z., Yin, Z., Zhang, Z., Zhao, J., Meng, Y., Li, R., Gao, Y., Zhang, H., Yu, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58333-0 · Cited by 14
“:3 β and 3 α :2 β ), Both assemblies are functional and have different biophysical properties, such as ligand binding af fi nity, ion permeability, and channel conductance 17,18 .”
Moonschi, F. H., Fox-Loe, A. M., Fu, X., & Richards, C. I. (2018) · BIO-PROTOCOL · doi:10.21769/bioprotoc.2825 · Cited by 12
“It has also been hypothesized that nicotine alters the assembly of this receptor from the low sensitivity to high sensitivity isoform in the ER leading to higher levels of the preferentially trafficked assembly in both the ER and plasma membrane (Lester et al., 2009; Henderson and Lester, 2015).”
BackgroundDjemil, S., Chen, X., Zhang, Z., Lee, J., Rauf, M., Pak, D. T. S., & Dzakpasu, R. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14938 · Cited by 13
“…the receptor level (Alkondon et al., 1994; Clarke, Schwartz, Paul, Pert, & Pert, 1985; Dani, 2015; Gray, Rajan, Radcliffe, Yakehiro, & Dani, 1996; Lester et al., 2009; Mansvelder & McGehee, 2000; Nelson, Kuryatov, Choi, Zhou, & Lindstrom, 2003) as well as in vivo (Barrass, Blackburn,…”
Antidepressants enter cells, organelles, and membranes
Blumenfeld, Z., Bera, K., Ċastrén, E., & Lester, H. A. (2023) · Neuropsychopharmacology · doi:10.1038/s41386-023-01725-x · Cited by 10
“In neuroscience, attention has also focused on drug accumulation in synaptic vesicles in axon terminals [66, 67].”
BackgroundSelf-citationSmoking flies: testing the effect of tobacco cigarettes on heart function ofDrosophila melanogaster
Santalla, M., Pagola, L., Gómez, I., Balcazar, D., Valverde, C. A., & Ferrero, P. (2021) · Biology Open · doi:10.1242/bio.055004 · Cited by 11
“Once inside the cell, it has been reported that nicotine binds to nascent nAChRs and acts as a stabilizing pharmacological chaperone, favouring the endoplasmic reticulum exit of nAChRs (Kuryatov et al., 2005; Sallette et al., 2005; Lester et al., 2009).”
BackgroundFoll, B. L., Chefer, S. I., Kimes, A. S., Stein, E. A., Goldberg, S. R., & Mukhin, A. G. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4250-9 · Cited by 9
“Nicotine upregulates nAChRs in both an intracellular compartment and on cell surface (Kuryatov et al. 2005; Lester et al. 2009; Lomazzo et al. 2011; Zambrano et al. 2012, 2015).”
Density of α4β2* nAChR on the surface of neurons is modulated by chronic antagonist exposure
Zambrano, C. A., Short, C. A., Salamander, R. M., Grady, S. R., & Marks, M. J. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.111 · Cited by 8
“The chaperone hypothesis postulates that the interaction of nicotine with surface receptors is not necessary for nAChR upregulation, but a concentration of the drug enough to bind and stabilize the specific nAChR subtype in the endoplasmic reticulum is required (Lester et al. 2009).”
BackgroundMicrotransplantation of human brain receptors into oocytes to tackle key questions in drug discovery
Zwart, R., Mazzo, F., & Sher, E. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.10.015 · Cited by 9
DNA methylation regulates CHRNA7 transcription and can be modulated by valproate
Dyrvig, M., Mikkelsen, J. D., & Lichota, J. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2019.04.015 · Cited by 9
Deba, F., Munoz, K., Peredia, E., Akk, G., & Hamouda, A. K. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101455 · Cited by 6
Nicotine modulates GABAergic transmission to dopaminergic neurons in substantia nigra pars compacta
Xiao, C., Yang, K., Zhou, C., Jin, G.-Z., Wu, J., & Ye, J. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.65 · Cited by 9
Self-citationPapke, R. L. (2023) · Advances in pharmacology · doi:10.1016/bs.apha.2023.08.001 · Cited by 9
Tsuzuki, A., Yamasaki, M., Konno, K., Miyazaki, T., Takei, N., Tomita, S., Yuzaki, M., & Watanabe, M. (2024) · Scientific Reports · doi:10.1038/s41598-024-65076-3 · Cited by 7
“Intracellular rather than cell surface nAChRs have been suggested as the pharmacological target of nicotine, which also boosts the cell surface localization of intracellular pools of nAChRs 62,63 .”
BackgroundInside job: ligand-receptor pharmacology beneath the plasma membrane
Babcock, J. J., & Li, M. (2013) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.51 · Cited by 7
Christensen, M. H., & Kohlmeier, K. A. (2014) · Addiction Biology · doi:10.1111/adb.12194 · Cited by 7
“Alternatively, nicotine-induced up-regulation of α4β2containing nAChR has also been suggested to occur by nicotine functioning as a stabilizing intracellular chaperone for this receptor constellation (Lester et al. 2009; Srinivasan et al. 2011).”
Han, Y., Zhang, J., Ji, Y., Luan, Y., Li, S.-Y., Geng, H.-Z., Ji, Y., Cui, Y., Liu, S., Zhou, C., et al. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01234-7 · Cited by 7
“This circuit pattern may explain protection of SNc dopaminergic neurons from excitotoxicity by chronic nicotine [61].”
Self-citationWichern, F., Jensen, M. M., Christensen, D. Z., Mikkelsen, J. D., Gondré‐Lewis, M. C., & Thomsen, M. S. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.01.026 · Cited by 6
“The cellular mechanisms by which nicotine produces upregulation of nAChRs are unknown, but it has been suggested to be due to a chaperoning effect of nicotine (Lester et al., 2009) or other posttranscriptional events (Govind et al.”
BackgroundNicotinic Acetylcholine Receptors
Papke, R. L. (2018) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780190669164.013.18 · Cited by 6
Fox-Loe, A. M., Dwoskin, L. P., & Richards, C. I. (2016) · Neuromethods · doi:10.1007/978-1-4939-3768-4_7 · Cited by 5
Dao, D. Q., Salas, R., & Biasi, M. D. (2014) · The Receptors · doi:10.1007/978-1-4939-1167-7_18 · Cited by 5
Wang, A. Z., Jeon, J., Drenan, R. M., & Lester, H. A. (2025) · Molecular Pharmacology · doi:10.1016/j.molpha.2025.100016 · Cited by 4
Self-citationUtilizing pHluorin-tagged Receptors to Monitor Subcellular Localization and Trafficking
Fox-Loe, A. M., Henderson, B. J., & Richards, C. I. (2017) · Journal of Visualized Experiments · doi:10.3791/55466 · Cited by 4
Effect of α7nAChR on learning and memory dysfunction in a rat model of diffuse axonal injury
Li, H., Sun, Z.-L., Pan, Y., Xu, M., & Feng, D. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111546 · Cited by 5
Preclinical Aspects of Nicotinic Acetylcholine Receptor Imaging
Brust, P., Deuther‐Conrad, W., Donat, C. K., Barthel, H., Riss, P. J., Paterson, L. M., Hoepping, A., Sabri, O., & Cumming, P. D. (2014) · Springer eBooks · doi:10.1007/978-3-642-42014-6_17 · Cited by 4
Leidenheimer, N. J. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00245 · Cited by 4
“…(Petaja-Repo et al., 2000, 2002; Janovick et al., 2002; Kuryatov et al., 2005; Sallette et al., 2005; Corringer et al., 2006; Van Craenenbroeck et al., 2006; Chen and Liu-Chen, 2009; Kobayashi et al., 2009; Lester et al., 2009; Eshaq et al., 2010; Srinivasan et al., 2011; Kusek et al., 2015).”
BackgroundMcManus, O. B., Werley, C. A., & Dempsey, G. T. (2019) · The Journal of General Physiology · doi:10.1085/jgp.201912325 · Cited by 3
“Although the consequences of inside-out signaling by nicotine are not fully elucidated, nicotine binding to nAChRs in the endoplasmic reticulum (ER) is known to stabilize the interface between α4 and β2 nAChR subunits, thereby chaperoning channels to the plasma membrane to increase surface expression and modify subuni…”
BackgroundPreclinical and Clinical Aspects of Nicotinic Acetylcholine Receptor Imaging
Brust, P., Deuther‐Conrad, W., Donat, C. K., Barthel, H., Riss, P. J., Paterson, L. M., Hoepping, A., Sabri, O., & Cumming, P. D. (2020) · Springer eBooks · doi:10.1007/978-3-030-53176-8_18 · Cited by 5
Ciudad‐Roberts, A., Camarasa, J., Pubill, D., & Escubedo, E. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2014.02.014 · Cited by 2
Environmental Pollutants on Angiogenesis and Vascular Development
Hong, X., Zhang, L., & Sun, Q. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64258-7 · Cited by 2
Jia, Y., Vega, C., Hinojosa, A., & Perales, J. (2025) · Toxicon · doi:10.1016/j.toxicon.2025.108438 · Cited by 2
Smoking Effects in the Human Nervous System
Schuman‐Olivier, Z., Stoeckel, L. E., Weisz, E., & Evins, A. E. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-418679-8.00011-3 · Cited by 2
Mondoloni, S., Nguyen, C., Vicq, É., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.16.472949 · Cited by 2
Nicotinic Receptors and Mental Illness
Leonard, S. S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1167-7_20 · Cited by 1
Contribution of Variants in CHRNB3/A6 Gene Cluster on Chromosome 8 to Smoking Dependence
Li, M. D. (2018) · Springer eBooks · doi:10.1007/978-981-10-7530-8_6 · Cited by 1
Mechanism of action of pinnatoxins E, F and G
Hellyer, S. D. (2014) · Otago University Research Archive (University of Otago) · Cited by 1
Daniello-Weltzen, M. M. (2011) · ScholarWorks - UA (University of Alaska System)
COPI polices nicotine-mediated up-regulation of nicotinic receptors
Anand, R. (2013) · The Journal of General Physiology · doi:10.1085/jgp.201311136
2Bs or not 2Bs: that is the question
Connolly, C. N. (2011) · The Journal of Physiology · doi:10.1113/jphysiol.2011.215350
Smith, D. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-4012
“…and Borzelleca, 1971) allows chronic nicotine exposure to upregulate nAChRs in cortex, midbrain, hippocampus, and hypothalamus (Marks et al, 1992; Nashmi et al, 2007), through selective pharmacological chaperoning of acetylcholine receptor and stoichiometry (SePhaChARNS; Lester et al, 2009).”
BackgroundFluorescence Microscopy of Nicotinic Acetylcholine Receptors
Dilworth, C. N. (2014) · CaltechTHESIS (California Institute of Technology) · doi:10.7907/z96d5qzb
Neurotransmitter Systems and the Nicotine Dependence-Induced Withdrawal Syndrome
Singh, T. G., Sharma, S., & Dhiman, S. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800213-1.00019-5
Expression, Pharmacological and Physiological Properties of Nicotinic Acetylcholine Receptors
Filchakova, O. (2014) · J. Willard Marriott Library · doi:10.26053/0h-qp7j-g500
Fox-Loe, A. M. (2016) · UKnowledge (University of Kentucky) · doi:10.13023/etd.2016.461
“such as nAChR, than typical anion channels [55].”
BackgroundInfluentialThe Biosynthesis and Folding of Oily Peptide Chains
Li, K., & Cai, S. (2019) · Springer eBooks · doi:10.1007/978-981-13-9077-7_5
Rescuing Dopamine Transporter Deficiency Syndrome
Sutton, C. (2018) · TSpace (University of Toronto)
Picciotto, M. R., & McClure‐Begley, T. D. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.718117889.793485283
Potential plant extracts in the treatment of Parkinson’s disease
Obulesu, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-95762-5.00003-5
Regulation of nAChR expression: Posttranscriptional regulation of nAChRs
Boyd, R. T. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-819958-9.00004-9
Impacts of Environmental Pollutants on Angiogenesis and Vascular Development
Zeng, X., Hong, X., & Sun, Q. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00176-5
Nicotine Attenuates Molecular Signalings in the BTBR T+ Itpr3tf/J Mouse Model of Autism
AlSharari, S. D., Mahmood, H. M., Alasmari, A. F., Aldhalaan, H., Alasmari, F. F., Khan, M. R., Ahmad, S. F., Aljasham, A. T., Damaj, M. I., & Alshammari, M. A. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04894-6 · Cited by 1
“Upregulated nAChRs also include α4β2 and α6 [79, 80].”
Allosteric Control of Super-Agonism in a Ligand-Gated Ion ChannelPreprint
Viscarra, F., Minguez, T., Bermúdez, I., & Biggin, P. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.23.655750
Environmental Pollutants on Angiogenesis and Vascular Development
Hong, X., Zhang, L., & Sun, Q. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.14026-4
Elucidating the Neural Threads: Role of CREB Modulation in Nicotine Addiction Mechanisms
Chhabra, L., Khan, H., Grewal, A. K., Dua, K., Gupta, G., Singh, S. K., & Singh, T. G. (2025) · Current Behavioral Neuroscience Reports · doi:10.1007/s40473-025-00313-1
“Several parallel processes, including adjustments in receptor construction, trafficking, and breakdown, result in the increased expression of nAChRs [30, 52].”
Diversité des effets de la nicotine sur les neurones dopaminergiques de l’aire tegmentale ventrale
Nguyen, C. (2020) · theses.fr (ABES) · doi:10.70675/57dc4740z36f1z4ee7z87e7z960af8c4a43e
Metadata
- Authors
- Lester, H. A., Xiao, C., Srinivasan, R., Son, C. D., Miwa, J., Pantoja, R., Banghart, M. R., Dougherty, D. A., Goate, A. M., & Wang, J. C.
- Affiliations
- California Institute of Technology (US)
- Harvard University (US)
- Washington University in St. Louis (US)
- Corresponding author
- Lester, Henry A.
- ORCID
- Venue
- The AAPS Journal
- Published
- 2009-03
- Volume
- 11
- Issue
- 1
- Pages
- 167-177
- ISSN
- 1550-7416 (ISSN-L)
- PMC
- PMC2664890
- OpenAlex
- W2083434249
- Semantic Scholar
- b9391525fc3ca03a6742aa0d414f0c2f757d6b9e
- Cited by
- 163
- References
- 131
- Citations by year
- 2025: 6 · 2024: 3 · 2023: 5 · 2022: 1 · 2021: 6 · 2020: 13 · 2019: 10 · 2018: 10 · 2017: 10 · 2016: 12 · 2015: 11 · 2014: 16 · 2013: 16 · 2012: 13
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- The AAPS Journal (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CaltechAUTHORS (California Institute of Technology) (submittedVersion)
- OpenMETU (Middle East Technical University) (submittedVersion, cc-by-nc-nd)
- Funders
- National Institute on Alcohol Abuse and Alcoholism (AA08401, U10AA008401)
- National Institute on Aging (R01AG033954, AG033954)
- National Institute on Drug Abuse (DA-19375, U19DA019375, DA17279, R01DA017279)
- National Cancer Institute (CA089392, P01CA089392)
- National Institute of Neurological Disorders and Stroke (NS34407, NS 11756, R01NS034407, R01NS011756, R37NS034407)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- nicotine, pharmacological chaperones, nicotinic acetylcholine receptors, receptor stoichiometry, receptor density, receptor up-regulation, chronic nicotine exposure, nicotine dependence, neural adaptation, Parkinson's disease, nocturnal frontal lobe epilepsy, receptor desensitization, receptor maturation, subunit interface, proteostasis, lynx, drug discovery
- MeSH terms
- Acetylcholine, Animals, Endoplasmic Reticulum, Hippocampus, Models, Biological, Muscle Proteins, Nerve Tissue Proteins, Nicotine, Parkinson Disease, Receptors, Nicotinic, Smoking, Tobacco Use Disorder, Up-Regulation, Epilepsy, Frontal Lobe, Ventral Tegmental Area, Neurotransmitter Agents, Mutation, Missense, Mice, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-08, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-08 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
